Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
chlorhexidingluconat 0,02 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % mundskyllevæske med pebermyntesmag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 5 % koncentreret opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,05 % topikal væske, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidingluconat 0,5 % i 70% IMS, til hånddesinfektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,5 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,02 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidingluconat 0,5 % i 70 % IMS, til kirurgisk desinfektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,12 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 1,2 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,6386 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 2,5 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat pink 0,05 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 0,05 %/0,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 1,5 %/15 % væske til topikal anvendelse, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 0,015 %/0,15 % topikal væske, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat opløsning 1,25 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat pink 0,5 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat blå 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat pink 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat + natriumnitrit 0,5 %/0,1 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidingluconat i IMS |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % + lidocainhydrochlorid 0,05 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 1 % + ethylalkohol 61 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 2 % + isopropylalkohol 70 % svamp til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
chlorhexidingluconat 3,15 %/isopropylalkohol 70 % vatpind til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Chlorhexidine digluconate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
2 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 1 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 1 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
chlorhexidingluconat + cetrimid 0,05 %/0,5 % opløsning |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine (as chlorhexidine gluconate) 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
2 |
Chlorhexidine gluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
2 |
Chlorhexidine gluconate 2 mg/mL and lidocaine hydrochloride 500 microgram/mL oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 2 mg/mL and lidocaine hydrochloride 500 microgram/mL oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate |
Inferred relationship |
Some |
1 |